file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 1233, GCS 5398, CR 10163 Collection span: 1951 - 2011 | |
Word(i) List (1171) Word count: 3979, All words count: 6034 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
301 | MEDICOLEGAL | 1 | 23 | 36 |
302 | SHIELDING | 1 | 20 | 36 |
303 | SITE | 1 | 20 | 36 |
304 | INSERT | 2 | 18 | 35 |
305 | ROUTE | 1 | 14 | 35 |
306 | TIME | 1 | 14 | 35 |
307 | VARYING | 1 | 14 | 35 |
308 | ANTIGENS | 13 | 19 | 34 |
309 | DEVELOPMENTS | 1 | 0 | 34 |
310 | DOSES | 5 | 16 | 34 |
311 | CLEFT | 5 | 10 | 33 |
312 | FACTORS | 2 | 8 | 33 |
313 | PALATE | 5 | 10 | 33 |
314 | VARIATIONS | 2 | 13 | 33 |
315 | FREQUENCY | 2 | 1 | 32 |
316 | MODELS | 1 | 1 | 32 |
317 | NONGENITAL | 2 | 8 | 32 |
318 | RATE | 1 | 13 | 32 |
319 | REICHERTS | 3 | 16 | 32 |
320 | SONOGRAPHY | 1 | 10 | 32 |
321 | VIVO | 1 | 1 | 32 |
322 | DEVELOPING | 5 | 13 | 31 |
323 | CAPROATE | 5 | 5 | 30 |
324 | GEL | 1 | 0 | 30 |
325 | GLASS | 1 | 0 | 30 |
326 | GRAINS | 2 | 8 | 30 |
327 | HYDROXYPROGESTERONE | 5 | 5 | 30 |
328 | IMMUNOGLOBIN | 1 | 0 | 30 |
329 | RELATION | 2 | 1 | 30 |
330 | SHEEP | 1 | 0 | 30 |
# | Word | Recs | TLCS | TGCS |
331 | SOL | 1 | 0 | 30 |
332 | TOXICITY | 5 | 9 | 30 |
333 | TRAPPED | 1 | 0 | 30 |
334 | VASCULATURE | 2 | 1 | 30 |
335 | 14TH | 3 | 11 | 29 |
336 | 18TH | 3 | 11 | 29 |
337 | COMPLEX | 1 | 5 | 29 |
338 | FUNCTIONS | 1 | 12 | 29 |
339 | GENETIC | 2 | 5 | 29 |
340 | MOLECULES | 1 | 12 | 29 |
341 | MULTIPLICITY | 1 | 5 | 29 |
342 | SMALL | 2 | 12 | 29 |
343 | COMMENT | 1 | 9 | 28 |
344 | DETERMINE | 2 | 1 | 28 |
345 | EDITORIAL | 1 | 9 | 28 |
346 | AGE | 5 | 3 | 27 |
347 | ALTERATIONS | 3 | 6 | 27 |
348 | ANENCEPHALY | 3 | 6 | 27 |
349 | BIFIDA | 5 | 6 | 27 |
350 | ENDOCHONDRAL | 5 | 10 | 27 |
351 | IMPORTANCE | 3 | 9 | 27 |
352 | OSSIFICATION | 2 | 10 | 27 |
353 | PREVENTABLE | 5 | 6 | 27 |
354 | SPINA | 3 | 6 | 27 |
355 | 12TH | 2 | 4 | 26 |
356 | 19TH | 2 | 4 | 26 |
357 | CHANGING | 4 | 2 | 26 |
358 | HAZARDS | 4 | 9 | 26 |
359 | ALKYLATED | 1 | 11 | 25 |
360 | DATA | 4 | 8 | 25 |
# | Word | Recs | TLCS | TGCS |
361 | DIGESTED | 1 | 11 | 25 |
362 | EPIDEMIC | 2 | 6 | 25 |
363 | METHIONINE | 5 | 12 | 25 |
364 | METHODS | 2 | 17 | 25 |
365 | REDUCED | 2 | 11 | 25 |
366 | TESTIMONY | 7 | 9 | 25 |
367 | UNNECESSARY | 2 | 6 | 25 |
368 | CASE | 4 | 6 | 24 |
369 | CONCEPTION | 2 | 11 | 24 |
370 | EXCHANGE | 2 | 14 | 24 |
371 | INCORPORATION | 2 | 12 | 24 |
372 | POOLS | 1 | 14 | 24 |
373 | WORKSHOP | 3 | 5 | 24 |
374 | AUTOIMMUNE | 1 | 10 | 23 |
375 | EMBRYOGENESIS | 3 | 10 | 23 |
376 | LETHAL | 1 | 14 | 23 |
377 | LOSS | 2 | 1 | 23 |
378 | MONOCLONAL | 7 | 17 | 23 |
379 | PHENOMENA | 1 | 10 | 23 |
380 | RESEARCH | 3 | 6 | 23 |
381 | TECHNIQUES | 3 | 10 | 23 |
382 | VULNERABILITY | 4 | 4 | 23 |
383 | ASSOCIATION | 1 | 5 | 22 |
384 | BLEEDING | 1 | 5 | 22 |
385 | CHORIONIC | 1 | 5 | 22 |
386 | LEUCINE | 5 | 7 | 22 |
387 | NICHHD | 1 | 5 | 22 |
388 | OCCURRENCE | 3 | 5 | 22 |
389 | PERSPECTIVES | 1 | 5 | 22 |
390 | PROVIDED | 1 | 5 | 22 |
# | Word | Recs | TLCS | TGCS |
391 | SAMPLING | 1 | 5 | 22 |
392 | SCHOLARSHIP | 6 | 7 | 22 |
393 | TERM | 2 | 8 | 22 |
394 | VILLOUS | 1 | 5 | 22 |
395 | CONCEPTUS | 4 | 11 | 21 |
396 | DAMAGE | 2 | 6 | 21 |
397 | DIAGNOSTIC | 4 | 3 | 21 |
398 | RECOVERY | 2 | 6 | 21 |
399 | TRANSAMINASE | 2 | 1 | 21 |
400 | VYS | 2 | 6 | 21 |
401 | WARNING | 2 | 10 | 21 |
402 | ADDITION | 1 | 5 | 20 |
403 | CONCENTRATION | 2 | 4 | 20 |
404 | ENRICHED | 1 | 5 | 20 |
405 | FLOUR | 1 | 5 | 20 |
406 | IMPROVING | 2 | 7 | 20 |
407 | QUALITY | 2 | 7 | 20 |
408 | RADIOIODINE | 2 | 4 | 20 |
409 | REFLEXES | 2 | 4 | 20 |
410 | REQUIRE | 1 | 5 | 20 |
411 | SUPPLY | 2 | 3 | 20 |
412 | THYROID | 3 | 4 | 20 |
413 | ULTRASTRUCTURE | 1 | 5 | 20 |
414 | DIRE | 1 | 10 | 19 |
415 | GLUTAMIC | 1 | 1 | 19 |
416 | IMMUNOLOGICALLY | 3 | 2 | 19 |
417 | MUTAGENIC | 1 | 9 | 19 |
418 | NEOPLASIA | 1 | 2 | 19 |
419 | OXALACETIC | 1 | 1 | 19 |
420 | PROTECTING | 1 | 9 | 19 |
# | Word | Recs | TLCS | TGCS |
421 | PUBLIC | 1 | 9 | 19 |
422 | ROENTGEN | 1 | 2 | 19 |
423 | TOO | 1 | 10 | 19 |
424 | UPTAKE | 5 | 2 | 19 |
425 | WARNINGS | 1 | 10 | 19 |
426 | CARCINOGENICITY | 1 | 5 | 18 |
427 | CHARACTERIZATION | 9 | 6 | 18 |
428 | CONSEQUENCES | 3 | 0 | 18 |
429 | DEFINITION | 1 | 5 | 18 |
430 | GENES | 1 | 0 | 18 |
431 | GENITAL | 2 | 6 | 18 |
432 | GLUCOCORTICOID | 6 | 7 | 18 |
433 | INFANT | 2 | 4 | 18 |
434 | KNOWN | 1 | 2 | 18 |
435 | MAN | 1 | 0 | 18 |
436 | MUTATIONS | 1 | 0 | 18 |
437 | NON | 6 | 2 | 18 |
438 | PERIOD | 4 | 4 | 18 |
439 | PROGESTATIONAL | 2 | 5 | 18 |
440 | TRANSGENIC | 1 | 0 | 18 |
441 | GESTATIONAL | 2 | 5 | 17 |
442 | HETEROLOGOUS | 3 | 2 | 17 |
443 | NUTRITION | 2 | 4 | 17 |
444 | OFFSPRING | 3 | 5 | 17 |
445 | THERAPY | 3 | 5 | 17 |
446 | ALLEGATION | 1 | 3 | 16 |
447 | C57B1 | 1 | 5 | 16 |
448 | CHAPTER | 1 | 3 | 16 |
449 | CONTRACEPTIVES | 1 | 8 | 16 |
450 | ENVELOPMENT | 1 | 7 | 16 |